Last updated: July 28, 2025
Introduction
Germany’s patent DE602007012292, filed under the European Patent Office and granted around 2008, pertains to a novel pharmaceutical invention. A comprehensive understanding of the patent’s scope, claims, and landscape is crucial for stakeholders such as pharmaceutical companies, generic manufacturers, and legal professionals. This analysis provides an in-depth examination, positioning the patent within the broader pharmaceutical innovation ecosystem.
Patent Overview and Filing Context
Patent DE602007012292 was filed by a major pharmaceutical entity, seeking protection over a specific chemical formulation or therapeutic use. The patent’s priority date traces back to 2007, aligning with a period marked by significant innovation in targeted therapies and pharmacokinetic enhancements, especially related to small molecules and biologics. The patent’s strategic scope aims to safeguard novel compounds, formulations, or methods of treatment.
Scope and Claims Analysis
Scope of the Patent
- Core Focus: The patent predominantly protects a chemical compound, a method of synthesis, or a therapeutic application. It might also encompass derivatives, salts, or polymorphs of a primary active component.
- Protection Breadth: The scope's breadth hinges on how expansively the claims are drafted—whether they cover a specific compound, a class of compounds, or a set of methods.
- Narrow claims might cover individual compounds with defined substitution patterns.
- Broader